arrow
J

Jonas Häner

University of Bern
H指数:16
被引数:1,544

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Derivation and external validation of a deep learning model to predict changes in coronary plaque burden

基于深度学习模型预测冠状动脉斑块负荷变化的推导与外部验证

2026-05-010
PRE
Silent plaque ruptures in non-obstructive lesions of non–infarct-related arteries: a multimodality, serial intracoronary imaging study

非梗死相关动脉非阻塞性病变中的静默斑块破裂:一项多模态、连续性冠状动脉成像研究

2026-03-090
PRE
A novel framework for fully automated co-registration of intravascular ultrasound and optical coherence tomography imaging data

一种用于完全自动化血管内超声与光学相干层析成像数据配准的新框架

2026-01-160
OA
A comprehensive workflow for CCTA and OCT data fusion with 3D printing validation: advancing patient-specific testing environments for percutaneous coronary intervention devices

一种用于CCTA和OCT数据融合及3D打印验证的全面工作流程:推进经皮冠状动脉介入治疗设备的患者特异性测试环境

2025-12-230
OAAI
Effect of Alirocumab on Coronary Plaque Stratified by Atherothrombotic Risk

阿利罗库玛单抗对冠状动脉斑块的影响:按动脉粥样血栓风险分层

2025-11-240
OAAI
Long-Term Outcomes in Moderate and Severe Aortic Stenosis According to Extent of Cardiac Damage

根据心脏损伤程度划分的中度和重度主动脉瓣狭窄的长期预后

2025-10-270
OAAI
Intake of high-intensity statin after acute myocardial infarction assessed by direct drug concentration measurement: association with LDL-C response and coronary plaque modifications in the PACMAN-AMI trial

急性心肌梗死后高剂量他汀类药物的摄入通过直接药物浓度测量进行评估:其在PACMAN-AMI试验中与LDL-C反应及冠状动脉斑块改变的相关性

2025-08-010
OAAI
Lesion-Level Effects of LDL-C-Lowering Therapy in Patients With Acute Myocardial Infarction A Post Hoc Analysis of the PACMAN-AMI Trial
2024-12-013
PRE
Long-term effect of biodegradable vs. durable polymer everolimus-eluting stents on neoatherosclerosis in ST-segment elevation myocardial infarction: the CONNECT trial
2024-09-011
OA
Effects of alirocumab on endothelial function and coronary atherosclerosis in myocardial infarction: A PACMAN-AMI randomized clinical trial substudy
2024-05-019
OAAI
Effect of Alirocumab Added to High-Intensity Statin on Platelet Reactivity and Noncoding RNAs in Patients with AMI: A Substudy of the PACMAN-AMI Trial
2023-09-117
PRE